SGTX 40% workforce reduction: https://www.globenewswire.com/news-release/2021/12/13/2351210/0/en/Sigilon-Therapeutics-Announces-Strategic-Reprioritization.html The stock is down 95% from its high one year ago, shortly after its IPO.